Ocular complications of inflammatory bowel disease

Scientific World Journal

Volumn 2015, Issue , 2015, Pages

  Mady, Rana ^a   Grover, Will ^a   Butrus, Salim ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CATARACTOGENESIS; CORTICOSTEROID THERAPY; DRY EYE; EPISCLERITIS; EYE DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; IRIDOCYCLITIS; IRITIS; KERATOPATHY; RETINOL DEFICIENCY; REVIEW; SCLERITIS; SCLEROMALACIA; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DRY EYE SYNDROMES; EYE DISEASES; INFLAMMATORY BOWEL DISEASES;

ADRENAL CORTEX HORMONES; ANIMALS; DRY EYE SYNDROMES; EYE DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; SCLERITIS;

EID: 84926676826     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2015/438402     Document Type: Review

References (19)

1. C. M. Fenoglio-Preiser, A. E. Noffsinger, G. N. Stemmermann, P. E. Lantz, and P. G. Isaacson, Gastrointestinal Pathology: An Atlas and Text, LippincottWilliams and Wilkins, Philadelphia, Pa, USA, 3rd edition, 2008.
2. R. Mintz, E. Feller, R. L. Bahr, and S. A. Shah, "Ocular manifestations of inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 10, no. 2, pp. 135-139, 2004.
3. J. F. Salmon, J. P. Wright, and A. D. N. Murray, "Ocular inflammation in Crohn's disease, " Ophthalmology, vol. 98, no. 4, pp. 480-484, 1991.
4. J. H. Krachmer, M. J. Mannis, and E. J. Holland, Cornea, Elsevier, 3rd edition, 2011.
5. J.-P. Hugot, P. Laurent-Puig, C. Gower-Rousseau et al., "Mapping of a susceptibility locus for Crohn's disease on chromosome 16, " Nature, vol. 379, no. 6568, pp. 821-823, 1996.
6. A. Karban, R. Eliakim, and S. R. Brant, "Genetics of inflammatory bowel disease, " IsraelMedical Association Journal, vol. 4, no. 10, pp. 798-802, 2002.
7. J. H. Cho, "The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease, " Inflammatory Bowel Diseases, vol. 7, no. 3, pp. 271-275, 2001.
8. R. H. Duerr, "The genetics of inflammatory bowel disease, " Gastroenterology Clinics of North America, vol. 31, no. 1, pp. 63-76, 2002.
9. B. Kleessen, A. J. Kroesen, H. J. Buhr, and M. Blaut, "Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls, " Scandinavian Journal of Gastroenterology, vol. 37, no. 9, pp. 1034-1041, 2002.
10. E. A. Petrelli, M. McKinley, and F. J. Troncale, "Ocular manifestations of inflammatory bowel disease, " Annals of Ophthalmology, vol. 14, no. 4, pp. 356-360, 1982.
11. D. D. J. Hopkins, E. Horan, I. L. Burton, S. E. Clamp, F. T. de Dombal, and J. C. Goligher, "Ocular disorders in a series of 332 patients with Crohn's disease, " British Journal of Ophthalmology, vol. 58, no. 8, pp. 732-737, 1974.
12. K. M. Das, "Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis, " Digestive Diseases and Sciences, vol. 44, no. 1, pp. 1-13, 1999.
13. E. G. Mallas, P. Mackintosh, P. Asquith, and W. T. Cooke, "Histocompatibility antigens in inflammatory bowel disease; their clinical significance and their associationwith arthropathy with special reference toHLAB27 (W27), " Gut, vol. 17, no. 11, pp. 906-910, 1976.
14. E. K. Akpek, J. E. Thorne, F. A. Qazi, D. V. Do, and D. A. Jabs, "Evaluation of patients with scleritis for systemic disease, " Ophthalmology, vol. 111, no. 3, pp. 501-506, 2004.
15. D. L. Knox, A. P. Schachat, and E. Mustonen, "Primary, secondary and coincidental ocular complications of Crohn's disease, " Ophthalmology, vol. 91, no. 2, pp. 163-173, 1984.
16. E. B. Suhler, J. R. Smith, M. S. Wertheim et al., "A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes, " Archives of Ophthalmology, vol. 123, no. 7, pp. 903-912, 2005.
17. F. R. Imrie and A. D. Dick, "Biologics in the treatment of uveitis, " Current Opinion in Ophthalmology, vol. 18, no. 6, pp. 481-486, 2007.
18. S. Ardizzone and G. B. Porro, "Biologic therapy for inflammatory bowel disease, " Drugs, vol. 65, no. 16, pp. 2253-2286, 2005.
19. P. Rutgeerts, G. Van Assche, and S. Vermeire, "Optimizing anti-TNF treatment in inflammatory bowel disease, " Gastroenterology, vol. 126, no. 6, pp. 1593-1610, 2004.